Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Similar herpes zoster incidence across Europe: results from a systematic literature review
2013
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain
2011
All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection
2012
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)
2013
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005–2012
2013
Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
2014
Bloodstream Infections
2008
Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
2017
Epidemiology of Herpes Zoster Infection among Patients Treated in Primary Care Centres in the Valencian Community (Spain)
2010
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
A prospective 12-month study of the effect of smoking cessation on periodontal clinical parameters
2011
Systematic review of incidence and complications of herpes zoster: towards a global perspective
2014 Standout
Hospitalizaciones por herpes zoster y neuralgia postherpética en Cataluña, 1998–2003
2011
Prevention and Control of Seasonal Influenza with Vaccines
2016
Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015
2016
Antifibrinolytic therapy to reduce haemoptysis from any cause
2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
2013
Peri‐implant disease in subjects with and without preventive maintenance: a 5‐year follow‐up
2011 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Works of F. Irisarri being referenced
Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study
2013
Mortality by causes in HIV-infected adults: comparison with the general population
2011
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12
2013
Situación de las enfermedades de declaración obligatoria (EDO) en Navarra, 2003
2004
Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Case-Control Study
2007
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: Cohort and case–control study
2011
Incidencia de la varicela y el herpes zóster antes de la introducción de la vacunación sistemática infantil en Navarra, 2005-2006
2008